Möller H J
Psychiatrische Klinik und Poliklinik, Universität Bonn.
Fortschr Med. 1993 Oct 10;111(28):437-40.
The possibilities and limitations of treatment of dementia with nootropic agents are discussed. Particular attention is directed to the calcium antagonist, nimodipine, with its demonstrably excellent efficacy. Treatment with nootropic agents should be initiated after meticulous establishment of the diagnosis of dementia and continued over the long-term, if their effectiveness is clinically manifest.
讨论了使用促智药治疗痴呆症的可能性和局限性。特别关注钙拮抗剂尼莫地平，其疗效显著优异。促智药治疗应在精确诊断痴呆症后开始，若其有效性在临床上显现，则应长期持续使用。
